India Pharma Outlook Team | Tuesday, 14 October 2025
Aurobindo Pharma's promoter group has successfully secured around 2,000 crore with a dual-tranche financing structure intended for platform acquisitions, which includes the Taj Banjara asset situated in Hyderabad.
The funds are being directed through the promoters' real estate division, Auro Realty.
The financing structure is segmented into two parts. The first part, Series 1, totals 650 crore and features a 24-month tenor along with a two-year put and call option. The second part, Series 2, amounts to 1,450 crore and has a four-year tenor. Series 1 is expected to carry a coupon rate of 11.75%, while Series 2 is projected to be priced at 15.5%.
Also Read: Cadila Pharmaceuticals Unveils Dlorfast-M for Allergy Relief
This debt is secured by a pledge of the promoters' special purpose vehicles, specifically Raidurgam Developers and Auro Realty, in addition to other tangible collateral. The total value of these assets surpasses 2,500 crore, supported by both personal and corporate guarantees.
Raidurgam Developers (RDL) manages the Galaxy Tower project located in Raidurgam, a suburb of Hyderabad that is home to numerous Indian companies, and mulitnational companies. The collateral coverage is approximately 2.5 times, increasing to about 4 times when including the additional guarantees.
Lenders are anticipated to have exit visibility through refinancing project cash flows, and the monetization of assets, including the upcoming LRD project. Aurobindo Pharma's spokesperson did not respond to requests for comments. The pharmaceutical company reported revenues approaching 31,000 crore and continues to uphold a net cash positive status.
